Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

05/02/2026 07:30

Feb 5 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Sep 30, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             15.90               13.00            59.25    
                 (+22.3 pct)         (+21.0 pct)      (+14.7 pct) 
  Operating          2.79                1.25             6.12    
                (+122.4 pct)                          (+22.6 pct) 
  Recurring          2.65                1.38             5.88    
                 (+92.8 pct)                          (+31.9 pct) 
  Net              324 mln             991 mln            2.24    
                 (-67.2 pct)         (-63.8 pct)      (-25.3 pct) 
  EPS             13.28 yen           40.75 yen        91.54 yen  
  Ann Div                             45.50 yen        47.00 yen  
  -Q2 div                             20.00 yen        21.00 yen  
  -Q4 div                             25.50 yen        26.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T